RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

PlainID, the leading provider of policy-based authorization solutions, announced its inclusion as a Representative Provider ...

BingX, a leading cryptocurrency exchange and Web3 AI company, hosted its exclusive affiliate gathering in Tenerife, Spain, uniting leading affiliates from different regions, key partners, and BingX ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express GenesEnables nucleic acids therapeutics research, ...

Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

Catalyst synthesis is the process of fabricating catalytic materials. It aims to optimize factors such as the catalyst activity, selectivity, stability and cost. Tuning the adsorption–desorption ...

Biosynthesis is the generation of natural products through enzymatic reactions, as in cellular metabolism. Successive enzymatic reactions by a number of enzymes are generally required to achieve a ...